Novitium Pharma's Generic Methyltestosterone Receives Approval in the U.S.
Enforcement Report - Week of July 10, 2019
Enforcement Report - Week of January 23, 2019
Impax Labs` Generic Methyltestosterone (10mg) approved in US for Hypogonadism (low-T)
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has approved its generic version of Testred Capsules 10 mg.